Canada: The Canadian Competition Bureau Releases Revised Intellectual Property Enforcement Guidelines

Last Updated: May 19 2016
Article by Andrea Kroetch

As previously reported, the Competition Bureau ("Bureau") released a revised version of its Intellectual Property Enforcement Guidelines ("IPEGs") on March 31, 2016, following an extensive public consultation process held in 2015 based on previous drafts released in 2014 and 2015.  

The IPEGs describe the Bureau's approach to conducting investigations under the Competition Act ("Act") in respect of anti-competitive activities that relate to intellectual property.  The primary revisions to the 2016 revised IPEGs (which represent the Bureau's first major update since the IPEGs original release in 2000) include clarification on the Bureau's position on patent settlements, product switching, the conduct of patent assertion entities, and conduct involving standard essential patent owners. 

Patent settlements

The 2016 revised IPEGs provide additional guidance on the Bureau's enforcement approach with respect to settlement agreements under the Patented Medicines (Notice of Compliance) Regulations (PMNOC Regulations), by identifying factors which will be considered in determining whether a settlement could give rise to competition law concerns under the civil provisions of the Act and by providing clarity as to when such agreements may be reviewed under the criminal provisions of the Act

Specifically, the Bureau indicates that in reviewing settlements for potential competition law concerns, consideration is to be had to the significant differences in the regulatory regimes governing pharmaceuticals in Canada relative to other jurisdictions which may have an impact on the terms and incentives related to settlements.  Such factors include, for example, the availability of exclusivity for the first generic filer, the availability of section 8 damages (brand liability to generic) and the possibility of dual litigation (parallel PMNOC and infringement proceedings) under the PMNOC Regulations, and as well, the significant price restrictions that both brand and generic firms typically face in Canada in order to have products listed on provincial formularies.

The Bureau also articulates its enforcement approach with respect to settlements, in particular identifying the types of settlement which may give rise to prosecution under the criminal provisions of the Act.  A summary of the Bureau's enforcement approach is set out below:

  1. A settlement in which the only consideration is allowing a generic market entry on or prior to patent expiry (an "entry-split settlement") will not pose an issue under the Act;
  2. A settlement with a payment to the generic pursuant to which the generic firm enters the market on or before patent expiry will be reviewed under the civil conspiracy provisions or the abuse of dominance provisions (an "entry-split with payment to generic settlement"); and
  3. The Bureau will review a settlement under the Act's criminal conspiracy provisions only in three specific circumstances, namely, where:

(a)   the parties agree that the generic will only enter the market after the date of patent expiry;

(b)  the settlement restricts competition for products unrelated to the patent subject to the PMNOC proceeding; or,

(c)   the settlement is a "sham" (e.g. where both parties knew the patent was invalid, but nevertheless reached a settlement to allocate monopoly profits by delaying generic entry).

Product switching

Under Canadian competition law, the mere exercise of an IP right is not cause for concern under the general provisions of the Competition Act

In the original IPEGs published in 2000, the "mere exercise" of an IP right was defined as including an "IP owner's use or non-use of the IP".  However, under the 2015 draft IPEGs the Bureau appeared to signal a change to this approach by removing the term "non-use" from its definition of "mere exercise" and by indicating that refusal to use IP could be challenged under the abuse of dominance provisions.  As an illustrative example of "non-use" abuse of dominance, the Bureau provided the example of "product switching" whereby a patentee removes a top-selling patented "Product A" that is about to lose patent protection, and replaces it with a similar patented "Product B" that has several years of patent protection remaining so as to force the market to switch to its new "Product B" thereby impeding market entry by other manufacturers after the expiry of the "Product A" patent.

In the 2016 revised IPEGs, the Bureau reverts back to its original position in that the "mere exercise" of an IP right once again is defined as including an "IP owner's use or non-use of the IP right"; however, the Bureau introduces a caveat, making clear that in some limited circumstances the non-use of an IP right could potentially raise issues under the general provisions of the Act.  

The Bureau also expands on its discussion of "patent switching" by creating a distinction between "hard" switching (the situation discussed above in which a patented product is removed from the market before the expiry of the patent to force a market to switch to a similar product which has several years of patent protection remaining) and "soft" switching (whereby a patentee does not withdraw a top-selling patented "Product A" from the market, but merely stops promoting "Product A" in favour of a similar patented "Product B" that has several years of patent protection remaining).  While the "hard switching" may be investigated under the Act's abuse of dominance provisions, "soft switching" is unlikely to raise concerns under the Act, provided that patentee's new marketing campaign did not involve false or misleading statements about the original product.

Conduct of patent assertion entities

Patent assertion entities ("PAE") are companies who acquire patents for the sole purpose of asserting them against firms allegedly infringing the patented technologies (i.e. they do not manufacture or sell products or services related to such patents). 

In the 2015 draft IPEGs, the Bureau indicated that the conduct of such companies would most likely be examined under the "false or misleading claims" provisions of the Act,  which prohibit making a representation to the public that is false or misleading in a material respect, or which is made knowingly and recklessly, respectively. 

In the 2016 revised IPEGs, the Bureau provides additional clarification as to when PAE conduct may or may not trigger investigation under the Act.  Specifically, the Bureau indicates that the assignment of a patent right to a PAE, simply for the purpose of more effective enforcement (with an agreement to split revenues from the enforcement of that patent), does not raise issues under the Act.  However, the Bureau reminds readers that conduct relating to assignments is potentially subject to review under the general provisions of the Act.

It is prudent to note, however, that the Bureau explicitly warns that the law with respect to PAEs is rapidly evolving and therefore the Bureau may revisit its guidance in this area in the future. 

Collaborative standard setting and standard essential patents

In the 2015 draft IPEGs the Bureau indicated that the development of standard essential patents through Standard Development Organizations or other means can pose competition concerns (e.g., patent hold up, patent ambush, reneging on a license commitment or seeking an injunction against willing licensees after making a licensing commitment).    

The 2016 revised IPEGs, clarify that the Bureau's guidance with respect to standard essential patents applies only in the context of standards developed through collaborative standards-setting activities.  That is, where companies come together to agree on industry standards that require the use of patented technology (i.e. Standard Development Organizations) and where holders of standard-essential patents have expressly committed to license those patents on fair, reasonable, and non-discriminatory ("FRAND") terms in return for their adoption in a standard.  The Bureau's guidance does not apply to "differentiating patents" (i.e. patents which have been widely adopted and are therefore "de facto" standards, but which have not been formally adopted as standardized technology).  

The 2016 revised IPEGs also clarify the Bureau's enforcement approach with respect to conduct involving standard essential patents.  A summary of the Bureau's enforcement approach is set out below:

  1. Conduct relating to the standard-setting process of a Standard Development Organization will be reviewed under the civil agreement between civil competitor provisions of the Act and not the criminal conspiracy provisions of the Act;
  2. Alleged anti-competitive conduct by the patentee of a standard essential patent (e.g. "patent ambush" and "patent hold-up" activities) will be reviewed under the abuse of dominance provision of the Act (rather than being treated only as a contractual dispute between the parties).

As in the case with PAEs (discussed above), the Bureau explicitly warns that it "may revisit certain aspects of the guidance in this subsection in the future in light of experience, changing circumstances and court decisions."


The 2016 revised IPEGs provide further clarity and guidance on the Bureau's approach to conducting investigations under the Act with respect to activities involving intellectual property, particularly in respect of the specific activities discussed above.  Intellectual property owners are therefore well-advised to review the 2016 revised IPEGs to ensure compliance with Canadian competition law.

For more information, please contact a member of our firm's IP Management & Strategic Counselling group.

The preceding is intended as a timely update on Canadian intellectual property and technology law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Andrea Kroetch
In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.